Dr. Jonathan S. Katz, MD

Dr. Katz practices at Sutter Pacific Medical Foundation in San Francisco, California.

Dr. Katz's NPI, 1457372823, was assigned on July 21, 2006. Dr. Katz graduated from Tulane School of Medicine in 1988. Dr. Katz holds California license A54410.

Dr. Katz's primary practice is Sutter Pacific Medical Foundation, at 1100 Van Ness Ave, San Francisco, CA 94109 in San Francisco County. The practice phone is (916) 732-4380.

Dr. Katz's primary practice is Sutter Pacific Medical Foundation in San Francisco, California. Dr. Katz is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Katz to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katz practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Katz's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Katz is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Katz's licenses on file in 3 states: California, Texas and Washington.

Dmand AI lists alzheimer's disease, carpal tunnel syndrome, fibromyalgia and chronic pain, head injury, hereditary polyneuropathy, lower back pain, muscle disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Katz treats.

CMS data shows 721 Medicare services from Dr. Katz across 15 procedure codes in 2024, for 339 Medicare patients. Medicare paid $86,401 for them.

CMS counts 339 Medicare patients who saw Dr. Katz in 2024. The largest group is 75 to 84, with 140 patients. 74% of them have high cholesterol, and 71% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katz's median patient age at 65, with 45% women.

In 2024, Dr. Katz wrote 1,114 Medicare Part D claims for 133 patients. 63% of them were for generic drugs. CMS names the drug for 994 of them, across 25 drugs with 11 or more claims each, at $5,911,041 in total drug cost. In 2023, CMS named 1,034 claims across 27 drugs.

Dr. Katz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Katz as offering telehealth.

Dmand AI links 69 papers to Dr. Katz, published from 2008 to 2024. 2013 was the busiest year, with 5. The most frequent topics are Amyotrophic Lateral Sclerosis, Disease Progression and Double-Blind Method. Dr. Katz has published most often in Muscle Nerve. Dr. Katz's most frequent co-authors are Robert Miller, MD, Carlayne E. Jackson, MD and Sharon P. Nations, MD.

Dmand AI links Dr. Katz to 4 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Amyotrophic Lateral Sclerosis, TDP-43 Proteinopathies and Muscular Atrophy, Spinal.

CMS Open Payments shows 520 general payments to Dr. Katz from 34 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Grifols Shared Services North America, Inc. paid the most, $155,882. It also lists 1 research payment totaling $2,797 in 2019.

Dr. Katz graduated from Tulane School of Medicine in 1988. Dr. Katz is a member of AAN.

Dr. Katz is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.